Cardiovascular Systems price target raised to $24 from $18 at Benchmark Co. Benchmark Co. raised its price target for Cardiovascular Systems to reflect its 2014 estimates and keeps a Buy rating on the stock.
News For CSII From The Last 14 Days
Check below for free stories on CSII the last two weeks.